Azor Biotek is developing microRNA-targeting small molecule therapeutics. Our lead therapeutics are designed to target miR-29 and miR-223 as multimodal tumor inhibitors.
Our design platform leverages high-throughput zebrafish phenotypic, molecular and pharmacokinetic data. We have therapeutic development pipelines in place for glioblastoma as well as neurodegenerative, fibrotic, cardiovascular and psychiatric indications.
Company Details
- Founded
- -
- Address
- Victoria, British Columbia V8s4t8, Ca
- Industry
- Pharmaceutical Manufacturing
- NAICS
-
Pharmaceutical and Medicine ManufacturingMedicinal and Botanical ManufacturingPharmaceutical Preparation ManufacturingIn-Vitro Diagnostic Substance ManufacturingBiological Product (except Diagnostic) Manufacturing
- Website
- http://azorbiotek.ca
- Keywords
- RNA.
- HQ
- Victoria, British Columbia
Azor Biotek Questions
Azor Biotek's website is http://azorbiotek.ca
Azor Biotek's LinkedIn profile is https://ca.linkedin.com/company/azor-biotek
Azor Biotek's industry is
Pharmaceutical Manufacturing
Azor Biotek's top competitors are
Bionxt Solutions,
Briacell Therapeutics Corp.,
Stressmarq Biosciences Inc.,
Kapoose Creek Bio,
Fusion Genomics Corporation,
Mhcombiotic Inc.,
Voxcell Bioinnovation,
Ipa (Immunoprecise Antibodies),
Eupraxia Pharmaceuticals Inc.,
Rjh Biosciences - Inspired Design, Effective Transfection.
Azor Biotek's categories are Pharmaceutical Manufacturing
Azor Biotek's founding year is 2019
